Home » Newsletters » BioWorld

BioWorld

Jan. 14, 1993

View Archived Issues

QUIDEL ACQUIRES DISTRIBUTOR

GYNEX LICENSES REGIMEN FOR ORAL CONTRACEPTIVES

ARGUS FILES FOR OFFERING

NEW CENTER FOR 'NATURAL' MEDICINES

CELLPRO FILES FOR OFFERING

AMYLIN PLANS PHASE II FOR DIABETES DRUG

BIOMATRIX AMENDS KABI PACT

BAXTER BEGINS BLOOD SUBSTITUTE TRIALS

SERAGEN REPORTS RESPONSE TO IL-2

REGENERON BEGINS PHASE II TRIALS FOR ALS

AIDS DRUG ENTERS PHASE II/III

PMA REPORTS FLOOD OF INDS

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...